Our previous randomized controlled trial and animal study found that MO could improve arthritis by decreasing pro-inflammatory factors (such as TNF-α and PGE2) and increasing anti-inflammatory factors (such as IL-10) (14, 16). The gene discussed is TNF; the disease is arthritic joint disease.